scholarly article | Q13442814 |
P356 | DOI | 10.1086/378810 |
P953 | full work available at URL | http://academic.oup.com/cid/article-pdf/37/9/1201/1395281/37-9-1201.pdf |
https://academic.oup.com/cid/article-pdf/37/9/1201/1395281/37-9-1201.pdf | ||
P698 | PubMed publication ID | 14557965 |
P50 | author | Jesus Blazquez | Q68273789 |
P2860 | cites work | Microbiology and Molecular Biology Reviews | Q6839270 |
Journal of Molecular Microbiology and Biotechnology | Q15767392 | ||
Molecular keys to speciation: DNA polymorphism and the control of genetic exchange in enterobacteria | Q24643432 | ||
beta-Lactamases in laboratory and clinical resistance | Q24669605 | ||
Replica plating and indirect selection of bacterial mutants | Q24676225 | ||
Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update | Q28143206 | ||
Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance | Q44144059 | ||
High Rate of Macrolide Resistance inStaphylococcus aureusStrains from Patients with Cystic Fibrosis Reveals High Proportions of Hypermutable Strains | Q44195004 | ||
Stress-induced mutagenesis in bacteria | Q44459277 | ||
Origin and molecular epidemiology of penicillin-binding-protein-mediated resistance to beta-lactam antibiotics | Q45058581 | ||
Fitness of an Escherichia coli Mutator Gene | Q45158915 | ||
High mutation frequencies among Escherichia coli and Salmonella pathogens | Q48057867 | ||
Molecular basis of streptomycin resistance in Mycobacterium tuberculosis: alterations of the ribosomal protein S12 gene and point mutations within a functional 16S ribosomal RNA pseudoknot | Q48104741 | ||
Molecular analysis of mutS expression and mutation in natural isolates of pathogenic Escherichia coli | Q48248666 | ||
Fitness of antibiotic-resistant microorganisms and compensatory mutations | Q50128492 | ||
Interspecies gene exchange in bacteria: the role of SOS and mismatch repair systems in evolution of species. | Q50144938 | ||
The barrier to recombination between Escherichia coli and Salmonella typhimurium is disrupted in mismatch-repair mutants | Q50192890 | ||
Insertional inactivation of mutS in Staphylococcus aureus reveals potential for elevated mutation frequencies, although the prevalence of mutators in clinical isolates is low. | Q52861291 | ||
A conspicuous adaptability to antibiotics in the Escherichia coli mutator strain, dnaQ49. | Q54085756 | ||
Role of mutator alleles in adaptive evolution. | Q54564129 | ||
Origin of bacterial variants. | Q55047163 | ||
Highly Variable Mutation Rates in Commensal and Pathogenic Escherichia coli | Q56944671 | ||
Nosocomial transmission of Mycobacterium bovis resistant to 11 drugs in people with advanced HIV-1 infection | Q57108909 | ||
Induction of the SOS response by new 4-quinolones | Q68220052 | ||
Induction of the SOS response in Escherichia coli by 4-quinolone antimicrobial agents | Q115692960 | ||
Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis | Q28248794 | ||
A constant rate of spontaneous mutation in DNA-based microbes | Q28271032 | ||
Comparative gene expression profiles following UV exposure in wild-type and SOS-deficient Escherichia coli | Q28364148 | ||
The mismatch repair system (mutS, mutL and uvrD genes) in Pseudomonas aeruginosa: molecular characterization of naturally occurring mutants | Q28492576 | ||
Characterization of MexT, the regulator of the MexE-MexF-OprN multidrug efflux system of Pseudomonas aeruginosa | Q28492704 | ||
Mismatch repair in replication fidelity, genetic recombination, and cancer biology | Q29616483 | ||
Escherichia coli mutator genes | Q33539352 | ||
Adaptation to the environment: Streptococcus pneumoniae, a paradigm for recombination-mediated genetic plasticity? | Q33826507 | ||
Horizontal gene transfer and the origin of species: lessons from bacteria. | Q33856631 | ||
Homeologous recombination and mismatch repair during transformation in Streptococcus pneumoniae: saturation of the Hex mismatch repair system | Q33883002 | ||
Evolution-driving genes | Q33949870 | ||
Analysis for a limited number of gene codons can predict drug resistance of Mycobacterium tuberculosis in a high-incidence community | Q33971262 | ||
Genetic characterization of highly fluoroquinolone-resistant clinical Escherichia coli strains from China: role of acrR mutations | Q33982113 | ||
Selection for high mutation rates in chemostats | Q33989687 | ||
No genetic barriers between Salmonella enterica serovar typhimurium and Escherichia coli in SOS-induced mismatch repair-deficient cells. | Q33994738 | ||
The SOS response: recent insights into umuDC-dependent mutagenesis and DNA damage tolerance | Q34090796 | ||
Mutator bacteria as a risk factor in treatment of infectious diseases | Q34113782 | ||
An elevated mutation frequency favors development of vancomycin resistance in Staphylococcus aureus | Q34142416 | ||
DnaE2 polymerase contributes to in vivo survival and the emergence of drug resistance in Mycobacterium tuberculosis | Q34191816 | ||
Resistance to antibiotics mediated by target alterations | Q34339223 | ||
High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. | Q34508854 | ||
Specialized DNA polymerases, cellular survival, and the genesis of mutations | Q34662609 | ||
Single amino acid replacements at positions altered in naturally occurring extended-spectrum TEM beta-lactamases. | Q35111013 | ||
Genetic analysis of clinical isolates of Streptococcus pneumoniae with high-level resistance to expanded-spectrum cephalosporins | Q35115272 | ||
Cross-resistance to fluoroquinolones in multiple-antibiotic-resistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reduction | Q35343881 | ||
Proliferation of mutators in A cell population | Q35618973 | ||
Characterization of a new TEM-type beta-lactamase resistant to clavulanate, sulbactam, and tazobactam in a clinical isolate of Escherichia coli. | Q35897209 | ||
Genetic characterization of multidrug-resistant Mycobacterium bovis strains from a hospital outbreak involving human immunodeficiency virus-positive patients | Q36544424 | ||
Selection of naturally occurring extended-spectrum TEM beta-lactamase variants by fluctuating beta-lactam pressure. | Q39474681 | ||
Genetic antagonism and hypermutability in Mycobacterium smegmatis | Q39538622 | ||
Penicillin-binding proteins 2b and 2x of Streptococcus pneumoniae are primary resistance determinants for different classes of beta-lactam antibiotics | Q39781766 | ||
A mutation in the D,D-carboxypeptidase penicillin-binding protein 3 of Streptococcus pneumoniae contributes to cefotaxime resistance of the laboratory mutant C604. | Q39784064 | ||
Adaptive evolution of highly mutable loci in pathogenic bacteria | Q40629814 | ||
Evolution and dissemination of beta-lactamases accelerated by generations of beta-lactam antibiotics | Q41311524 | ||
Lack of evidence for involvement of hypermutability in emergence of vancomycin-intermediate Staphylococcus aureus | Q42859651 | ||
Mismatch repair and the regulation of phase variation in Neisseria meningitidis | Q43612705 | ||
Induction of SOS genes in Escherichia coli and mutagenesis in Salmonella typhimurium by fluoroquinolones | Q43680076 | ||
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1201-1209 | |
P577 | publication date | 2003-09-30 | |
P1433 | published in | Clinical Infectious Diseases | Q5133764 |
P1476 | title | Hypermutation as a factor contributing to the acquisition of antimicrobial resistance | |
Hypermutation as a Factor Contributing to the Acquisition of Antimicrobial Resistance | |||
P478 | volume | 37 |
Q40230898 | Adaptive tuning of mutation rates allows fast response to lethal stress in Escherichia coli |
Q35534934 | Anti-biofilm compounds derived from marine sponges |
Q38392008 | Antibiotic discovery: combatting bacterial resistance in cells and in biofilm communities. |
Q41937031 | Antibiotic resistance in Pseudomonas aeruginosa strains with increased mutation frequency due to inactivation of the DNA oxidative repair system. |
Q26752527 | Antimicrobial Drugs in Fighting against Antimicrobial Resistance |
Q37356533 | Antimicrobial resistance: its emergence and transmission |
Q37794342 | Bacterial hypermutation in cystic fibrosis, not only for antibiotic resistance |
Q86832377 | Bypass of genetic constraints during mutator evolution to antibiotic resistance |
Q64263651 | Continuous culture of Escherichia coli, under selective pressure by a novel antimicrobial complex, does not result in development of resistance |
Q40968218 | Detection and susceptibility testing of hypermutable Pseudomonas aeruginosa strains with the Etest and disk diffusion |
Q90365037 | Development of amoxicillin resistance in Escherichia coli after exposure to remnants of a non-related phagemid-containing E. coli: an exploratory study |
Q50056870 | Distribution of mutation frequencies among Salmonella enterica isolates from animal and human sources and genetic characterization of a Salmonella Heidelberg hypermutator |
Q90148668 | Dynamic Emergence of Mismatch Repair Deficiency Facilitates Rapid Evolution of Ceftazidime-Avibactam Resistance in Pseudomonas aeruginosa Acute Infection |
Q41833848 | Effect of ciprofloxacin concentration on the frequency and nature of resistant mutants selected from Pseudomonas aeruginosa mutS and mutT hypermutators |
Q42577782 | Effect of subinhibitory concentrations of antibiotics on intrachromosomal homologous recombination in Escherichia coli |
Q41991607 | Fluoroquinolone resistance in Haemophilus influenzae is associated with hypermutability. |
Q39990097 | Fosfomycin and rifampin disk diffusion tests for detection of Escherichia coli mutator strains |
Q95840911 | Genes and Proteomes Associated With Increased Mutation Frequency and Multidrug Resistance of Naturally Occurring Mismatch Repair-Deficient Salmonella Hypermutators |
Q28486002 | Genetic and genomic architecture of the evolution of resistance to antifungal drug combinations |
Q35666138 | Genomic Comparison of Non-Typhoidal Salmonella enterica Serovars Typhimurium, Enteritidis, Heidelberg, Hadar and Kentucky Isolates from Broiler Chickens |
Q41104415 | Genomic diversity of Mycobacterium tuberculosis Beijing strains isolated in Tuscany, Italy, based on large sequence deletions, SNPs in putative DNA repair genes and MIRU-VNTR polymorphisms |
Q44350722 | Hypermutable Staphylococcus aureus strains present at high frequency in subclinical bovine mastitis isolates are associated with the development of antibiotic resistance |
Q33770211 | Hypermutable and fluoroquinolone-resistant clinical isolates of Staphylococcus aureus |
Q37922538 | Hypermutation and stress adaptation in bacteria |
Q41974061 | Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections |
Q89766030 | Hypermutator Pseudomonas aeruginosa exploits multiple genetic pathways to develop multidrug resistance during long-term infections in the airways of cystic fibrosis patients |
Q40593170 | Hypermutator Salmonella Heidelberg induces an early cell death in epithelial cells |
Q39609549 | Increased mutation frequencies in Escherichia coli isolates harboring extended-spectrum beta-lactamases |
Q43181792 | Induction and inhibition of ciprofloxacin resistance-conferring mutations in hypermutator bacteria |
Q34073057 | Induction of resistant mutants of Salmonella enterica serotype Typhi under ciprofloxacin selective pressure |
Q60921824 | Inhibiting the Evolution of Antibiotic Resistance |
Q42705384 | Intermediate mutation frequencies favor evolution of multidrug resistance in Escherichia coli |
Q39955018 | Lack of association between hypermutation and antibiotic resistance development in Pseudomonas aeruginosa isolates from intensive care unit patients |
Q34057563 | Long-term dissemination of CTX-M-5-producing hypermutable Salmonella enterica serovar typhimurium sequence type 328 strains in Russia, Belarus, and Kazakhstan |
Q37512348 | Multiple strategies for translesion synthesis in bacteria |
Q35869358 | Mutation as a stress response and the regulation of evolvability |
Q92752649 | Mutation rate variability as a driving force in adaptive evolution |
Q34550797 | Mutational spectrum drives the rise of mutator bacteria |
Q81404551 | Mutations in DNA repair genes are associated with the Haarlem lineage of Mycobacterium tuberculosis independently of their antibiotic resistance |
Q37678002 | Mutators and hypermutability in bacteria: the Escherichia coli paradigm |
Q37184072 | Mycobacterium tuberculosis mutation rate estimates from different lineages predict substantial differences in the emergence of drug-resistant tuberculosis |
Q50044377 | Optimization of a meropenem plus tobramycin combination dosage regimen against hypermutable and non-hypermutable Pseudomonas aeruginosa via mechanism-based modeling and the hollow-fiber infection model. |
Q34297656 | Pharmacokinetics and pharmacodynamics of aerosolized antibacterial agents in chronically infected cystic fibrosis patients |
Q30230558 | Plant pathogen forensics: capabilities, needs, and recommendations |
Q33482815 | Role of mutation in Pseudomonas aeruginosa biofilm development. |
Q21144990 | SOS response induces persistence to fluoroquinolones in Escherichia coli |
Q40943537 | SOS-independent induction of dinB transcription by beta-lactam-mediated inhibition of cell wall synthesis in Escherichia coli. |
Q30974317 | Simple sequence repeats and mucoid conversion: biased mucA mutagenesis in mismatch repair-deficient Pseudomonas aeruginosa. |
Q28269575 | Small molecule control of bacterial biofilms |
Q35754447 | Targets for Combating the Evolution of Acquired Antibiotic Resistance |
Q33386642 | The Pseudomonas aeruginosa pfpI gene plays an antimutator role and provides general stress protection |
Q22065663 | The emergence of antibiotic resistance by mutation |
Q51594842 | [Chronic bronchial infection: the problem of Pseudomonas aeruginosa]. |
Search more.